New Nobel Prize winners tell the Boston Globe that science funding these days is uncertain.
The New York Times writes that US lawmakers have rejected President Trump's proposal to cut NIH funding.
The law broadens the ability of law enforcement agencies to use rapid DNA sequencing technology and upload resulting data into a federal database.
CBS News reports that the science division of the White House's Office of Science and Technology Policy has no more staffers, though the White House says it does.
President Donald Trump has nominated Jerome Adams as surgeon general, Politico reports.
The Bidens have convened a diverse board and staff with the goal of continuing efforts to accelerate research and development begun under the Cancer Moonshot Initiative.
The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.
An opinion piece appearing at Stat News wonders why a budget cut is being sought for the National Institutes of Health.
President Donald Trump is to name the University of North Carolina-Chapel Hill's Norman Sharpless as director of the National Cancer Institute.
President Donald Trump has announced that Francis Collins will remain director of the US National Institutes of Health.
The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.
Kaiser Health News reports that gene therapies could cost more than a million dollars.
Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.
In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.